Trust evidence,
not marketing.

Most people buy from a UK peptide retailer on the strength of the retailer's own claims. PeptideClear checks the evidence first: what a business can actually prove about its testing, its identity and its conduct, not what it says about itself.

The UK reference

PeptideClear Trust Index

Independent transparency assessments of UK research-peptide retailers, built from what each business publishes and what the public record shows. Nobody is charged to be included, and nobody can pay for a better result.

Showing Testing Transparency only — one of three separate pillars, not an overall grade
39 of 151 assessed retailers publish full, verifiable per‑batch testing (grade A− or above)
A+A−BCD
159assessed
195reviewed & tracked
1independently verified
Open the full Trust Index →

Testing Transparency signals only, not an overall Trust Index grade · six published signals · last refreshed 21 August 2026

How retailers are assessed

Three separate measures. Never blended into one score.

A retailer can do well on one and poorly on another; nothing here is averaged into a single letter or number.

01 · TESTING TRANSPARENCY

What can we verify about their testing?

Per-batch certificate of analysis, from a named third-party lab, checkable against the lab's own records.

02 · BUSINESS TRANSPARENCY

Can we establish who is behind it?

Whether a matching UK trading entity can be confirmed on the public record. A gap is a fact we couldn't establish, not wrongdoing.

03 · RESPONSIBLE PRACTICE

Does conduct match the research-only claim?

Whether a retailer's site and marketing hold to its "research use only" positioning, checked against a published standard.

Independent Verification

A materially deeper assessment

Undertaken on request, published either way: a structured, 8-area digital evidence assessment that goes well beyond the free baseline.

Independently verified

54 checks · 8 areas

Lab authenticity, batch and report traceability, corporate reality, regulatory footprint, catalogue and legality, business conduct, and a claims/marketing audit. Payment buys the labour of running the checks, not the result.

One UK retailer has completed it so far: Ascend Peptides UK, verified 18 August 2026. Its baseline results are unchanged by verification.

Search & AI visibility

Increasingly part of how this market gets researched

Trust intent
78.5%

of PeptideClear's traffic arrives already trying to work out whether a specific peptide supplier can be trusted — reviews, comparisons and “is this retailer legitimate” research, not general browsing.

SEARCH
144Google page one · 57 top three · 41 at #1
159Bing page one · 71 top three · 29 at #1
AI DISCOVERY
2,270AI Overview appearances
15,000+recorded AI-crawler reads
14,000+of those in past 30 days

Google Search Console data, PeptideClear analysis, current as of August 2026. “AI reads” counts confirmed fetches by AI crawlers (GPTBot, ClaudeBot, PerplexityBot and others): it shows AI systems retrieving PeptideClear's pages, not that a specific AI answer named PeptideClear.

Beyond the Trust Index

Four areas, one evidence standard

Research asset

The Evidence Map

27 compounds placed by how far their evidence actually goes, animal work through to human randomised trials. One view shows where a compound really sits. Open the full map →

Editor's desk

Latest from PeptideClear

MHRA · REGULATORY

UK first in Europe to authorise orforglipron for weight management and type 2 diabetes

What the approval covers, who it applies to, and what it changes for the wider GLP-1 market.

GUIDE

How to verify a certificate of analysis yourself, not just take our score on trust.

METHODOLOGY

What changed in the 21 August Trust Index refresh, and why.

Independence

We are not a pharmacy, a clinic, or a retailer

PeptideClear does not sell peptides, dispense medication or prescribe. Nobody pays to be listed or scored in the baseline Trust Index, and nobody can pay for a better result. Independent Verification is a paid service, commissioned and invoiced separately from PeptideClear's editorial work: the fee buys the labour of running the checks, not the outcome.

How we're funded →Methodology →